Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A Chabner

Showing results (231-240 of 245) with videos related to

Pageof 25
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Paclitaxel administration using portable infusion pumpsB R Goldspiel, D R Kohler, A G Koustenis, et al.
Journal of the National Cancer Institute|August 2, 1989
4-Ipomeanol: a novel investigational new drug for lung cancerM C Christian, R E Wittes, B Leyland-Jones, et al.
Drugs|July 1, 1978
Antineoplastic drugs: clinical pharmacology and therapeutic useR A Bender, L A Zwelling, J H Doroshow, et al.
The New England Journal of Medicine|December 7, 1978
Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapyR C Young, B A Chabner, S P Hubbard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomasW H Wilson, B A Chabner, G Bryant, et al.
Cancer Treatment Reports|May 1, 1979
Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputationS A Rosenburg, B A Chabner, R C Young, et al.
The New England Journal of Medicine|January 27, 1983
Unstable methotrexate resistance in human small-cell carcinoma associated with double minute chromosomesG A Curt, D N Carney, K H Cowan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trialsJ A O'Shaughnessy, R E Wittes, G Burke, et al.
The New England Journal of Medicine|October 15, 1987
Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndromeC J Allegra, B A Chabner, C U Tuazon, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1988
Bioavailability of oral trimetrexate in patients with acquired immunodeficiency syndromeP Rogers, C J Allegra, R F Murphy, et al.
Pageof 25

Showing results (231-240 of 245) with videos related to

Sort By:
Pageof 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Paclitaxel administration using portable infusion pumpsB R Goldspiel, D R Kohler, A G Koustenis, et al.
Journal of the National Cancer Institute|August 2, 1989
4-Ipomeanol: a novel investigational new drug for lung cancerM C Christian, R E Wittes, B Leyland-Jones, et al.
Drugs|July 1, 1978
Antineoplastic drugs: clinical pharmacology and therapeutic useR A Bender, L A Zwelling, J H Doroshow, et al.
The New England Journal of Medicine|December 7, 1978
Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapyR C Young, B A Chabner, S P Hubbard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomasW H Wilson, B A Chabner, G Bryant, et al.
Cancer Treatment Reports|May 1, 1979
Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputationS A Rosenburg, B A Chabner, R C Young, et al.
The New England Journal of Medicine|January 27, 1983
Unstable methotrexate resistance in human small-cell carcinoma associated with double minute chromosomesG A Curt, D N Carney, K H Cowan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trialsJ A O'Shaughnessy, R E Wittes, G Burke, et al.
The New England Journal of Medicine|October 15, 1987
Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndromeC J Allegra, B A Chabner, C U Tuazon, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1988
Bioavailability of oral trimetrexate in patients with acquired immunodeficiency syndromeP Rogers, C J Allegra, R F Murphy, et al.
Pageof 25